Changes in insulin and insulin signaling in Alzheimer's disease: Cause or consequence?

161Citations
Citations of this article
276Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Individuals with type 2 diabetes have an increased risk for developing Alzheimer's disease (AD), although the causal relationship remains poorly understood. Alterations in insulin signaling (IS) are reported in the AD brain. Moreover, oligomers/fibrils of amyloid-ß (Aß) can lead to neuronal insulin resistance and intranasal insulin is being explored as a potential therapy for AD. Conversely, elevated insulin levels (ins) are found in AD patients and high insulin has been reported to increase Aß levelsand tau phosphorylation, which could exacerbate AD pathology. Herein, we explore whether changes in ins and IS are a cause or consequence of AD.

Cite

CITATION STYLE

APA

Stanley, M., Macauley, S. L., & Holtzman, D. M. (2016). Changes in insulin and insulin signaling in Alzheimer’s disease: Cause or consequence? Journal of Experimental Medicine, 213(8), 1375–1385. https://doi.org/10.1084/jem.20160493

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free